13 Recruiting Non-small Cell Lung Cancer (NSCLC) Clinical Trials in California
Explore active non-small cell lung cancer (nsclc) research studies enrolling across California. Verify eligibility and contact site coordinators.
📍 Find Near Me by DistanceBrowse by City
Recruiting Non-small Cell Lung Cancer (NSCLC) Studies in California
Sacituzumab Tirumotecan (MK-2870) Versus Pemetrexed and Carboplatin Combination Therapy in Participants With Epidermal Growth Factor (EGFR)-Mutated, Advanced Nonsquamous Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Prior EGFR Tyrosine Kinase Inhibitors (MK-2870-009)
📍 Kaiser Permanente - Oakland ( Site 0054) — Oakland, California
View Study & Checklist ➔HER3-DXd (Patritumab Deruxtecan; U3-1402) in Combination With Osimertinib in Subjects With Locally Advanced or Metastatic EGFR-mutated Non-Small Cell Lung Cancer
📍 UCLA — Santa Monica, California
View Study & Checklist ➔U3-1402 in Metastatic or Unresectable Non-Small Cell Lung Cancer
📍 City of Hope — Duarte, California
View Study & Checklist ➔Study of Osimertinib and Stereotactic Ablative Radiation (SABR) in EGFR Mutant NSCLC
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations (MK-2870-004)
📍 UCLA Hematology/Oncology - Santa Monica ( Site 0023) — Los Angeles, California
View Study & Checklist ➔Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
📍 City of Hope — Duarte, California
View Study & Checklist ➔A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)
📍 Providence Medical Foundation - Fullerton - Virginia K. Crosson Cancer Center — Fullerton, California
View Study & Checklist ➔A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
📍 Sansum Clinic — Santa Barbara, California
View Study & Checklist ➔Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
📍 UC Irvine/Chao Family Comprehensive Cancer Center — Orange, California
View Study & Checklist ➔Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)
📍 UCLA — Los Angeles, California
View Study & Checklist ➔Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
📍 Compassionate Cancer Care Center — Fountain Valley, California
View Study & Checklist ➔Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
📍 University of California, Davis Comprehensive Cancer Center — Sacramento, California
View Study & Checklist ➔A Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell Lung Cancer With a KRAS G12D Mutation
📍 Oncura Health d.b.a.Los Angeles Cancer Network — Glendale, California
View Study & Checklist ➔